Clinical trial Recruiting at 1 site Observational Ages 18 and up

Force feedback in robotic lung resection: does gentler instrument touch help recovery?

Official title: Evaluating the Association of Force Feedback With Outcomes After Lung Resection Using the da Vinci Multiport System

Run by Ohio State University · NCT07660900 · Data updated 2026-11-12

This study tests whether using Force Feedback instruments during robotic lobectomy or segmentectomy leads to faster recovery and fewer complications for adults undergoing these procedures.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment270 (estimated)
SponsorOhio State University
Academic / other
Locations1 site (Columbus, Ohio)
StatusRecruiting
StartedSeptember 5, 2025
Main results expectedJune 30, 2027
Study endsDecember 31, 2027
Registry record updatedJune 22, 2026
Trial IDNCT07660900 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older undergoing robotic-assisted lobectomy or segmentectomy at The Ohio State University Wexner Medical Center.

Probably not a fit

Patients who do not experience benefit may include those with factors driving longer recovery regardless of instrument force, such as severe comorbidities or non-ERAS pathway deviations.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will prospectively follow patients undergoing robotic-assisted anatomic lung resections (lobectomy or segmentectomy) at The James Cancer Hospital to see if lower force at the instrument tips is linked to better outcomes. Researchers will compare outcomes using Force Feedback devices, aiming to capture a composite endpoint of textbook recovery, defined by uncomplicated recovery, early discharge, and no readmission. The study focuses on real-world clinical practice at a high-volume thoracic center and aims to determine whether force reduction improves postoperative trajectories. The investigators hypothesize that reduced force with Force Feedback instruments will increase rates of discharge within three days after surgery. All eligible adults undergoing robotic-assisted lung resection who meet ERAS criteria at OSU Wexner Medical Center will be observed.

Why it matters

Potential benefit: If successful, the approach could help surgeons optimize instrument use to shorten hospital stays and reduce complications after robotic lung surgery.

How similar studies have gone: Prior research in robotic surgery has explored haptic feedback and instrument force, with mixed results; this study applies a targeted outcome in a high-volume thoracic setting to clarify potential benefits.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ages 18 years or older
* Undergoing robotic-assisted anatomic lung resection (lobectomy or segmentectomy) at The Ohio State University Wexner Medical Center

Exclusion Criteria:

* Age \< 18 years old
* Subject is pregnant or suspected to be pregnant or breastfeeding
* ECOG Performance status \> 2
* Do not qualify for ERAS protocol
* Undergoing an emergent procedure
* Undergoing non-anatomic lung resection
* Undergoing pneumonectomy
* Previous ipsilateral thoracic surgery (open, video-assisted thoracoscopic or robotic)
* Planned to undergo major concomitant surgery for the treatment of a different medical condition than was originally planned
* Non-English speaking

Where it's running

  • The James Cancer Hospital
    Columbus, Ohio, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.